XML 112 R10.htm IDEA: XBRL DOCUMENT v3.25.0.1
Label Element Value
Risk Return Abstract rr_RiskReturnAbstract  
Registrant Name dei_EntityRegistrantName THE ALGER FUNDS
Prospectus Date rr_ProspectusDate Feb. 28, 2025
Class A C Shares | Alger Health Sciences Fund - AC  
Risk Return Abstract rr_RiskReturnAbstract  
Risk/Return [Heading] rr_RiskReturnHeading <span style="color:#262626;font-family:Arial;font-size:10pt;font-weight:bold;text-transform:uppercase;">Alger Health Sciences Fund</span>
Objective [Heading] rr_ObjectiveHeading <span style="color:#0064FA;font-family:Arial;font-size:10pt;font-weight:bold;">Investment Objective</span>
Objective, Primary [Text Block] rr_ObjectivePrimaryTextBlock Alger Health Sciences Fund seeks long-term capital appreciation.
Expense [Heading] rr_ExpenseHeading <span style="color:#0064FA;font-family:Arial;font-size:10pt;font-weight:bold;">Fund Fees and Expenses</span>
Expense Narrative [Text Block] rr_ExpenseNarrativeTextBlock This table describes the fees and expenses that you may pay if you buy, hold and sell shares of the Fund. You may pay other fees, such as brokerage commissions and other fees to financial intermediaries, which are not reflected in the table and examples below.You may qualify for sales charge discounts if you and your family invest, or agree to invest in the future, at least $25,000 in Class A Shares of the Alger Family of Funds, including the Fund. More information about these and other discounts is available from your financial professional and in “Purchasing and Redeeming Fund Shares” on page 69 and in Appendix A – Waivers and Discounts Available from Intermediaries on page A-1 in the Fund’s Prospectus, and in the sections “Right of Accumulation (Class A Shares)” and “Letter of Intent (Class A)” beginning on page 38 of the Fund’s Statement of Additional Information.
Shareholder Fees Caption [Text] rr_ShareholderFeesCaption <span style="color:#262626;font-family:Arial;font-size:9pt;font-weight:bold;">Shareholder Fees</span> <br/><span style="color:#262626;font-family:Arial;font-size:9pt;">(fees paid directly from your investment)</span>
Operating Expenses Caption [Text] rr_OperatingExpensesCaption <span style="color:#262626;font-family:Arial;font-size:9pt;font-weight:bold;">Annual Fund Operating Expenses</span> <br/><span style="color:#262626;font-family:Arial;font-size:9pt;">(expenses that you pay each year as a percentage of the value of your investment)</span>
Portfolio Turnover [Heading] rr_PortfolioTurnoverHeading <span style="color:#0064FA;font-family:Arial;font-size:10pt;font-weight:bold;">Portfolio Turnover</span>
Portfolio Turnover [Text Block] rr_PortfolioTurnoverTextBlock The Fund pays transaction costs, such as commissions, when it buys and sells securities (or “turns over” its portfolio). A higher portfolio turnover rate may indicate higher transaction costs and may result in higher taxes when Fund shares are held in a taxable account. These costs, which are not reflected in annual fund operating expenses or in the examples, affect the Fund’s performance. During the most recent fiscal year, the Fund’s portfolio turnover rate was 233.38% of the average value of its portfolio.
Portfolio Turnover, Rate rr_PortfolioTurnoverRate 233.38%
Expenses Deferred Charges [Text Block] rr_ExpensesDeferredChargesTextBlock Purchases of $1 million or more of Class A Shares at net asset value may be subject to a contingent deferred sales charge of 1.00% on redemptions made within 12 months of purchase.
Expense Breakpoint Discounts [Text] rr_ExpenseBreakpointDiscounts <span style="color:#262626;font-family:Arial;font-size:9pt;">You may qualify for sales charge discounts if you and your family invest, or agree to invest in the future, at least </span><span style="color:#262626;font-family:Arial;font-size:9pt;">$25,000</span><span style="color:#262626;font-family:Arial;font-size:9pt;"> in Class A Shares of the Alger Family of Funds, including the Fund.</span>
Expense Breakpoint, Minimum Investment Required [Amount] rr_ExpenseBreakpointMinimumInvestmentRequiredAmount $ 25,000
Expense Example [Heading] rr_ExpenseExampleHeading <span style="color:#0064FA;font-family:Arial;font-size:9pt;font-weight:bold;">Example</span>
Expense Example Narrative [Text Block] rr_ExpenseExampleNarrativeTextBlock The following examples are intended to help you compare the cost of investing in the Fund with the cost of investing in other funds. The examples assume that you invest $10,000 in the Fund for the time periods indicated and then redeem all of your shares at the end of those periods, that your investment has a 5% return each year and that the Fund’s operating expenses remain the same. Although your actual costs may be higher or lower, based on these assumptions your costs would be:
Expense Example, No Redemption, By Year, Caption [Text] rr_ExpenseExampleNoRedemptionByYearCaption <span style="color:#262626;font-family:Arial;font-size:8pt;font-weight:bold;">You would pay the following expenses if you did not redeem your shares:</span>
Strategy [Heading] rr_StrategyHeading <span style="color:#0064FA;font-family:Arial;font-size:10pt;font-weight:bold;">Principal Investment Strategy</span>
Strategy Narrative [Text Block] rr_StrategyNarrativeTextBlock Fred Alger Management, LLC (the “Manager”) believes companies undergoing Positive Dynamic Change offer the best opportunities. Positive Dynamic Change refers to companies realizing High Unit Volume Growth or companies undergoing Positive Lifecycle Change. High Unit Volume Growth companies are traditional growth companies experiencing, for example, rapidly growing demand or market dominance. Positive Lifecycle Change companies are, for example, companies benefitting from new regulations, a new product innovation or new management.Under normal circumstances, the Fund invests at least 80% of its net assets, plus any borrowings for investment purposes, in equity securities of companies of any market capitalization that are engaged in the health sciences sector. Equity securities include common or preferred stocks that are listed on U.S. or foreign exchanges. A company will be considered to be engaged in the health sciences sector if it derives at least 50% of its earnings or revenues from, or devotes at least 50% of its assets to, activities in any area of the health sciences sector, including health care services, pharmaceuticals, medical equipment and supplies and applied research and development. Such companies include, but are not limited to: hospitals, clinical test laboratories, convalescent and mental health care facilities, home care providers, and companies that supply services to any of the foregoing; companies involved in pharmaceuticals, biotechnology, biochemistry and diagnostics; and producers and manufacturers of medical, dental and optical supplies and equipment.The Fund may invest a substantial portion of its assets in a smaller number of issuers. Fund holdings may occasionally increase or decrease for a variety of reasons, including, among others, because of extreme market volatility, such as when the Fund has entered a temporary defensive position.  Additionally, the Fund may exceed its current number of holdings for a number of reasons, including, but not limited to, when it acquires a new holding and determines that it is in the best interests of shareholders to sell an existing holding over a period of time, instead of immediately selling the entire holding.The Fund may sell a stock when it reaches a target price, it fails to perform as expected, or other opportunities appear more attractive. As a result, the Fund may engage in active trading of portfolio securities.The Fund can also invest in privately placed securities, which are securities acquired in non-public offerings for which there is no readily available market.The Fund can invest in foreign securities.The Fund may invest in cash (and cash equivalents) when the Fund is unable to find enough attractive long-term investments to meet its investment objective, to meet redemptions and/or when the Manager believes it is advisable to do so during times of short-term market volatility. During these times, cash (and cash equivalents) will not exceed 15% of the Fund’s net assets.
Risk [Heading] rr_RiskHeading <span style="color:#0064FA;font-family:Arial;font-size:10pt;font-weight:bold;">Principal Risks</span>
Bar Chart and Performance Table [Heading] rr_BarChartAndPerformanceTableHeading <span style="color:#0064FA;font-family:Arial;font-size:10pt;font-weight:bold;">Performance</span>
Performance Narrative [Text Block] rr_PerformanceNarrativeTextBlock The following bar chart and the table beneath it provide some indication of the risks of investing in the Fund by showing changes in the Fund’s performance from year to year and by showing how the Fund’s average annual returns for the indicated periods compare with those of an appropriate broad-based securities market index that represents the overall domestic equity market and a more narrowly based index that reflects the market sectors in which the Fund invests. Performance in the bar chart does not reflect the effect of the sales charge imposed on purchases of Class A Shares of the Fund. If the bar chart reflected the applicable sales charges, returns would be less than those shown.The Fund’s past performance (before and after taxes) is not necessarily an indication of how it will perform in the future. Updated performance information is available on the Fund’s website www.alger.com. The Fund compares its performance to the S&P 500 Index, a broad based measure of market performance. The Fund also compares its performance to the Russell 3000 Health Care Index (the “Health Care Index”). The Health Care Index provides a more complete comparison of Fund performance relative to companies involved in the medical services or health care field.
Performance Information Illustrates Variability of Returns [Text] rr_PerformanceInformationIllustratesVariabilityOfReturns <span style="color:#262626;font-family:Arial;font-size:9pt;">The following bar chart and the table beneath it provide some indication of the risks of investing in the Fund by showing changes in the Fund’s performance from year to year and by showing how the Fund’s average annual returns for the indicated periods compare with those of an appropriate broad-based securities market index that represents the overall domestic equity market</span><span style="color:#262626;font-family:Arial;font-size:9pt;line-height:11pt;"> </span><span style="color:#262626;font-family:Arial;font-size:9pt;">and a more narrowly based index that reflects the market sectors in which the Fund invests. </span>
Performance Additional Market Index [Text] rr_PerformanceAdditionalMarketIndex <span style="color:#262626;font-family:Arial;font-size:9pt;">The Fund also </span><span style="color:#262626;font-family:Arial;font-size:9pt;">compares its performance to the Russell 3000 Health Care Index (the “Health Care Index”). The Health Care Index provides a more complete comparison of Fund performance relative to companies involved in the medical services or health care field.</span>
Performance Availability Website Address [Text] rr_PerformanceAvailabilityWebSiteAddress <span style="color:#262626;font-family:Arial;font-size:9pt;">www.alger.com</span>
Performance Past Does Not Indicate Future [Text] rr_PerformancePastDoesNotIndicateFuture <span style="color:#262626;font-family:Arial;font-size:9pt;">The Fund’s past performance (before and after taxes) is not necessarily an indication of how it will perform in the future.</span>
Bar Chart [Heading] rr_BarChartHeading <span style="color:#262626;font-family:Arial;font-size:10pt;font-weight:bold;">Annual Total Return for Class A Shares</span><span style="color:#262626;font-family:Arial;font-size:10pt;line-height:12pt;"> </span><span style="color:#262626;font-family:Arial;font-size:10pt;font-style:italic;">as of December 31 (%)</span>
Bar Chart Does Not Reflect Sales Loads [Text] rr_BarChartDoesNotReflectSalesLoads <span style="color:#262626;font-family:Arial;font-size:9pt;">Performance in the bar chart does not </span><span style="color:#262626;font-family:Arial;font-size:9pt;">reflect the effect of the sales charge imposed on purchases of Class A Shares of the Fund. If the bar chart reflected the applicable sales charges, returns would be less than those shown.</span>
Bar Chart Closing [Text Block] rr_BarChartClosingTextBlock Best Quarter:Q2 202024.45%Worst Quarter:Q4 2018-18.72%
Performance Table Heading rr_PerformanceTableHeading <span style="color:#0064FA;font-family:Arial;font-size:10pt;font-weight:bold;">Average Annual Total Return as of December 31, 2024</span>
Performance Table Uses Highest Federal Rate rr_PerformanceTableUsesHighestFederalRate <span style="color:#262626;font-family:Arial;font-size:9pt;">after-tax returns are calculated using the historical highest individual federal marginal income tax rates and </span><span style="color:#262626;font-family:Arial;font-size:9pt;">do not reflect the impact of state and local taxes.</span>
Performance Table Not Relevant to Tax Deferred rr_PerformanceTableNotRelevantToTaxDeferred <span style="color:#262626;font-family:Arial;font-size:9pt;">Actual after-tax returns depend on an investor’s tax situation and may differ from those shown. The after-tax returns shown may not be relevant to investors who hold their Fund shares through tax-deferred arrangements, such as 401(k) plans or individual retirement accounts.</span>
Performance Table One Class of after Tax Shown [Text] rr_PerformanceTableOneClassOfAfterTaxShown <span style="color:#262626;font-family:Arial;font-size:9pt;">After-tax returns for Class C Shares, which are not shown, will vary from those shown for Class A Shares.</span>
Performance Table Explanation after Tax Higher rr_PerformanceTableExplanationAfterTaxHigher <span style="color:#262626;font-family:Arial;font-size:9pt;">A “Return After Taxes on Distributions and Sale of Fund Shares” may sometimes be higher than the other two return figures; this happens when there is a capital loss on redemptions, giving rise to a tax benefit to the shareholder.</span>
Performance Table Narrative rr_PerformanceTableNarrativeTextBlock In the foregoing table, after-tax returns are calculated using the historical highest individual federal marginal income tax rates and do not reflect the impact of state and local taxes.Actual after-tax returns depend on an investor’s tax situation and may differ from those shown. The after-tax returns shown may not be relevant to investors who hold their Fund shares through tax-deferred arrangements, such as 401(k) plans or individual retirement accounts.After-tax returns for Class C Shares, which are not shown, will vary from those shown for Class A Shares.A “Return After Taxes on Distributions and Sale of Fund Shares” may sometimes be higher than the other two return figures; this happens when there is a capital loss on redemptions, giving rise to a tax benefit to the shareholder.
Class A C Shares | Alger Health Sciences Fund - AC | Risk Lose Money [Member]  
Risk Return Abstract rr_RiskReturnAbstract  
Risk [Text Block] rr_RiskTextBlock The Fund’s share price may go down, which means you could lose money.
Class A C Shares | Alger Health Sciences Fund - AC | Risk Not Insured Depository Institution [Member]  
Risk Return Abstract rr_RiskReturnAbstract  
Risk [Text Block] rr_RiskTextBlock An investment in the Fund is not a deposit of a bank and is not insured or guaranteed by the Federal Deposit Insurance Corporation or any other government agency.
Class A C Shares | Alger Health Sciences Fund - AC | Investment Risk [Member]  
Risk Return Abstract rr_RiskReturnAbstract  
Risk [Text Block] rr_RiskTextBlock Investment Risk – An investment in the Fund is subject to investment risk, including the possible loss of the entire principal amount that you invest.
Class A C Shares | Alger Health Sciences Fund - AC | Market Risk [Member]  
Risk Return Abstract rr_RiskReturnAbstract  
Risk [Text Block] rr_RiskTextBlock Market Risk – Your investment in Fund shares represents an indirect investment in the securities owned by the Fund. The value of these securities, like other investments, may move up or down, sometimes rapidly and unpredictably. Your Fund shares at any point in time may be worth less than what you invested, even after taking into account the reinvestment of Fund dividends and distributions. Local, regional or global events such as environmental or natural disasters, war, terrorism, pandemics, outbreaks of infectious diseases, and similar public health threats, recessions, or other events could have a significant impact on the Fund and its investments.
Class A C Shares | Alger Health Sciences Fund - AC | Equity Securities Risk [Member]  
Risk Return Abstract rr_RiskReturnAbstract  
Risk [Text Block] rr_RiskTextBlock Equity Securities Risk – As with any fund that invests in stocks, your investment will fluctuate in value, and the loss of your investment is a risk of investing. The Fund’s price per share will fluctuate due to changes in the market prices of its investments. Also, the Fund’s investments may not grow as fast as the rate of inflation and stocks tend to be more volatile than some other investments you could make, such as bonds.
Class A C Shares | Alger Health Sciences Fund - AC | Growth Securities Risk [Member]  
Risk Return Abstract rr_RiskReturnAbstract  
Risk [Text Block] rr_RiskTextBlock Growth Securities Risk – Prices of growth stocks tend to be higher in relation to their companies’ earnings and may be more sensitive to market, political and economic developments than other stocks, making their prices more volatile. An investment in the Fund may be better suited to investors who seek long-term capital growth and can tolerate fluctuations in their investment’s value.
Class A C Shares | Alger Health Sciences Fund - AC | Small Cap Securities Risk [Member]  
Risk Return Abstract rr_RiskReturnAbstract  
Risk [Text Block] rr_RiskTextBlock Small Cap Securities Risk – There may be greater risk in investing in companies with small market capitalizations rather than larger, more established companies owing to such factors as more limited product lines or financial resources or lack of management depth. It may also be difficult or impossible to liquidate a security position at a time and price acceptable to the Fund because of the potentially less frequent trading of stocks of smaller market capitalization.
Class A C Shares | Alger Health Sciences Fund - AC | Concentration Risk [Member]  
Risk Return Abstract rr_RiskReturnAbstract  
Risk [Text Block] rr_RiskTextBlock Concentration Risk – By focusing on an industry or a group of industries, the Fund carries much greater risks of adverse developments and price movements in such industries than a fund that invests in a wider variety of industries. Because the Fund concentrates in a specific industry or group of industries, there is also the risk that the Fund will perform poorly during a slump in demand for securities of companies in such industries.
Class A C Shares | Alger Health Sciences Fund - AC | Health Care Sector Risk [Member]  
Risk Return Abstract rr_RiskReturnAbstract  
Risk [Text Block] rr_RiskTextBlock Health Care Sector Risk – The Fund may have a significant portion of its assets invested in securities of healthcare companies. At times, the performance of healthcare companies will lag the performance of other industries or the broader market as a whole, and the performance of such companies may be more volatile. Healthcare companies may also be significantly affected by intense competition, aggressive pricing, government regulation, technological innovations, product obsolescence, patent considerations, product compatibility and consumer preferences.
Class A C Shares | Alger Health Sciences Fund - AC | Small Number of Holdings Risk [Member]  
Risk Return Abstract rr_RiskReturnAbstract  
Risk [Text Block] rr_RiskTextBlock Small Number of Holdings Risk – Under normal circumstances, the Fund invests in a small number of issuers. Therefore, the Fund’s performance may be more vulnerable to changes in the market value of a single issuer and more susceptible to risks associated with a single economic, political, or regulatory occurrence than a fund that has a higher number of holdings.
Class A C Shares | Alger Health Sciences Fund - AC | Privately Placed Securities Risk [Member]  
Risk Return Abstract rr_RiskReturnAbstract  
Risk [Text Block] rr_RiskTextBlock Privately Placed Securities Risk – A private placement is an offering of a company’s securities that is not registered with the Securities and Exchange Commission (the “SEC”) and is not offered to the public. The issuers of privately placed securities are not typically subject to the same oversight and regulatory requirements, including disclosure and other investor protection requirements, to which public issuers are subject, and there may be very little public information available about the issuers and their performance. The sale or transfer of privately placed securities may be limited or prohibited by contract or law and such investments are generally considered to be illiquid. Privately placed securities are generally fair valued as they are not traded frequently. The Fund may be required to hold such positions for several years, if not longer, regardless of valuation, which may cause the Fund to be less liquid. As a result, investments in private placements can result in substantial or complete losses.
Class A C Shares | Alger Health Sciences Fund - AC | Foreign Securities Risk [Member]  
Risk Return Abstract rr_RiskReturnAbstract  
Risk [Text Block] rr_RiskTextBlock Foreign Securities Risk – The Fund’s performance will be influenced by political, social and economic factors affecting investments in foreign companies. Special risks associated with investments in foreign companies include exposure to currency fluctuations, lack of liquidity, potential for market manipulation, less developed or less efficient trading markets, limited access to reliable capital, lack of comprehensive company information, political instability, differing audit, regulatory, and legal standards and lack of financial reporting standards.
Class A C Shares | Alger Health Sciences Fund - AC | Portfolio Turnover Active Trading Risk [Member]  
Risk Return Abstract rr_RiskReturnAbstract  
Risk [Text Block] rr_RiskTextBlock Portfolio Turnover (Active Trading) Risk – Because the Fund may engage in active trading of portfolio securities, it may incur increased transaction costs and brokerage commissions, both of which can lower the actual return on an investment. Active trading may also increase short-term gains and losses, which may affect the taxes a shareholder has to pay.
Class A C Shares | Alger Health Sciences Fund - AC | Cash Position Risk [Member]  
Risk Return Abstract rr_RiskReturnAbstract  
Risk [Text Block] rr_RiskTextBlock Cash Position Risk – At times, the Fund may hold up to 15% of its net assets in cash (and cash equivalents), which may underperform relative to equity securities.
Class A C Shares | Alger Health Sciences Fund - AC | Class A  
Risk Return Abstract rr_RiskReturnAbstract  
Maximum sales charge (load) imposed on purchases as a % of offering price rr_MaximumSalesChargeImposedOnPurchasesOverOfferingPrice 5.25%
Maximum deferred sales charge (load) as a % of purchase price or redemption proceeds, whichever is lower rr_MaximumDeferredSalesChargeOverOfferingPrice none [1]
Advisory Fees rr_ManagementFeesOverAssets 0.55%
Distribution and/or Service (12b-1) Fees rr_DistributionAndService12b1FeesOverAssets 0.25%
Other Expenses rr_OtherExpensesOverAssets 0.38%
Total Annual Fund Operating Expenses rr_ExpensesOverAssets 1.18%
1 Year rr_ExpenseExampleYear01 $ 639
3 Years rr_ExpenseExampleYear03 880
5 Years rr_ExpenseExampleYear05 1,140
10 Years rr_ExpenseExampleYear10 $ 1,882
2015 rr_AnnualReturn2015 2.35%
2016 rr_AnnualReturn2016 (3.31%)
2017 rr_AnnualReturn2017 37.16%
2018 rr_AnnualReturn2018 5.79%
2019 rr_AnnualReturn2019 22.03%
2020 rr_AnnualReturn2020 30.98%
2021 rr_AnnualReturn2021 2.50%
2022 rr_AnnualReturn2022 (17.04%)
2023 rr_AnnualReturn2023 (4.26%)
2024 rr_AnnualReturn2024 1.17%
Highest Quarterly Return, Label rr_HighestQuarterlyReturnLabel <span style="color:#262626;font-family:Arial;font-size:8pt;font-weight:bold;">Best Quarter:</span>
Highest Quarterly Return, Date rr_BarChartHighestQuarterlyReturnDate Jun. 30, 2020
Highest Quarterly Return rr_BarChartHighestQuarterlyReturn 24.45%
Lowest Quarterly Return, Label rr_LowestQuarterlyReturnLabel <span style="color:#262626;font-family:Arial;font-size:8pt;font-weight:bold;">Worst Quarter:</span>
Lowest Quarterly Return, Date rr_BarChartLowestQuarterlyReturnDate Dec. 31, 2018
Lowest Quarterly Return rr_BarChartLowestQuarterlyReturn (18.72%)
1 Year rr_AverageAnnualReturnYear01 (4.12%)
5 Years rr_AverageAnnualReturnYear05 0.44%
10 Years rr_AverageAnnualReturnYear10 6.00%
Inception Date rr_AverageAnnualReturnInceptionDate May 01, 2002
Class A C Shares | Alger Health Sciences Fund - AC | Class C  
Risk Return Abstract rr_RiskReturnAbstract  
Maximum sales charge (load) imposed on purchases as a % of offering price rr_MaximumSalesChargeImposedOnPurchasesOverOfferingPrice none
Maximum deferred sales charge (load) as a % of purchase price or redemption proceeds, whichever is lower rr_MaximumDeferredSalesChargeOverOfferingPrice 1.00%
Advisory Fees rr_ManagementFeesOverAssets 0.55%
Distribution and/or Service (12b-1) Fees rr_DistributionAndService12b1FeesOverAssets 1.00%
Other Expenses rr_OtherExpensesOverAssets 0.35%
Total Annual Fund Operating Expenses rr_ExpensesOverAssets 1.90%
1 Year rr_ExpenseExampleYear01 $ 293
3 Years rr_ExpenseExampleYear03 597
5 Years rr_ExpenseExampleYear05 1,026
10 Years rr_ExpenseExampleYear10 2,222
1 Year rr_ExpenseExampleNoRedemptionYear01 193
3 Years rr_ExpenseExampleNoRedemptionYear03 597
5 Years rr_ExpenseExampleNoRedemptionYear05 1,026
10 Years rr_ExpenseExampleNoRedemptionYear10 $ 2,222
1 Year rr_AverageAnnualReturnYear01 (0.37%)
5 Years rr_AverageAnnualReturnYear05 0.77%
10 Years rr_AverageAnnualReturnYear10 5.92%
Inception Date rr_AverageAnnualReturnInceptionDate May 01, 2002
Class A C Shares | Alger Health Sciences Fund - AC | Return After Taxes on Distributions | Class A  
Risk Return Abstract rr_RiskReturnAbstract  
1 Year rr_AverageAnnualReturnYear01 (4.12%)
5 Years rr_AverageAnnualReturnYear05 (1.37%)
10 Years rr_AverageAnnualReturnYear10 4.15%
Class A C Shares | Alger Health Sciences Fund - AC | Return After Taxes on Distributions and Sale of Shares | Class A  
Risk Return Abstract rr_RiskReturnAbstract  
1 Year rr_AverageAnnualReturnYear01 (2.44%)
5 Years rr_AverageAnnualReturnYear05 0.34%
10 Years rr_AverageAnnualReturnYear10 4.53%
Class A C Shares | Alger Health Sciences Fund - AC | S&P 500 Index (reflects no deductions for fees, expenses or taxes)  
Risk Return Abstract rr_RiskReturnAbstract  
1 Year rr_AverageAnnualReturnYear01 25.02%
5 Years rr_AverageAnnualReturnYear05 14.53%
10 Years rr_AverageAnnualReturnYear10 13.10%
Class A C Shares | Alger Health Sciences Fund - AC | Russell 3000 Health Care Index (reflects no deductions for fees, expenses or taxes)  
Risk Return Abstract rr_RiskReturnAbstract  
1 Year rr_AverageAnnualReturnYear01 3.48%
5 Years rr_AverageAnnualReturnYear05 7.18%
10 Years rr_AverageAnnualReturnYear10 8.81%
[1] Purchases of $1 million or more of Class A Shares at net asset value may be subject to a contingent deferred sales charge of 1.00% on redemptions made within 12 months of purchase.